Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Subclinical hypothyroidism: how should it be managed?

Vahab Fatourechi1

  • 1Division of Endocrinology, Metabolism, Diabetes, Nutrition, and Internal Medicine, Mayo Clinic, Rochester, Minnesota 55905, USA.

Treatments in Endocrinology
|April 1, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Follow-up and Outcomes of 186 Patients With Follicular Cell-Derived Thyroid Cancer Seen at a Referral Center by One Thyroidologist in 2015.

Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists·2024
Same author

Stable thyroid cancer in a patient with thoracic aortic aneurysm and MYH11 variation.

Endocrinology, diabetes & metabolism case reports·2024
Same author

Long-Term Results of Treating With Ethanol Ablation 15 Adult Patients With cT1aN0 Papillary Thyroid Microcarcinoma.

Journal of the Endocrine Society·2020
Same author

A Prospective, Randomized, Double-blind, Placebo-controlled Study of Orbital Radiotherapy for Graves' Ophthalmopathy.

Ophthalmology·2020
Same author

Subclinical hypothyroidism and subclinical hyperthyroidism.

Expert review of endocrinology & metabolism·2019
Same author

An update on subclinical hypothyroidism and subclinical hyperthyroidism.

Expert review of endocrinology & metabolism·2019

Subclinical hypothyroidism, or mild thyroid failure, involves elevated thyroid-stimulating hormone (TSH) with normal thyroid hormones. Treatment decisions for milder forms require individualized assessment, especially for patients with TSH below 10 mIU/L.

Area of Science:

  • Endocrinology
  • Internal Medicine

Background:

  • Subclinical hypothyroidism is characterized by elevated serum thyrotropin hormone (TSH) with normal thyroxine and liothyronine levels.
  • This condition, also termed mild thyroid failure, represents a significant portion of elevated TSH cases.
  • While therapy is agreed upon for TSH levels above 10 mIU/L, treatment for milder forms remains controversial.

Purpose of the Study:

  • To review the current understanding and management of subclinical hypothyroidism.
  • To highlight the controversies in treating milder forms of the condition.
  • To provide recommendations for individualized patient management.

Main Methods:

  • Review of existing randomized clinical trials and medical literature.
  • Analysis of factors influencing treatment decisions in subclinical hypothyroidism.

Related Experiment Videos

  • Discussion of diagnostic indicators and patient subgroups.

    • Main Results:

    • Therapy is uniformly recommended for sustained TSH increases above 10 mIU/L.
    • Randomized trials for TSH levels below 10 mIU/L are inconclusive due to lack of subgroup stratification.
    • Factors like goiter, positive thyroperoxidase (TPO) antibodies, and pregnancy favor treatment initiation.
    • Children and adolescents with mild thyroid failure warrant treatment due to growth and development concerns.
    • The role of subclinical hypothyroidism as a cardiovascular risk factor requires further investigation.

    Conclusions:

    • Individualized management is recommended for patients with TSH levels below 10 mIU/L.
    • Positive TPO antibodies strongly indicate the need for therapy due to high progression risk to overt hypothyroidism.
    • Further randomized studies are needed to resolve therapeutic controversies and clarify cardiovascular risks.